NEXTBio Capital Management LP: 13F holdings
CIK 20381582026Q2
| Positions | 22 |
|---|---|
| Reported value | $217.4m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| PTGX PROTAGONIST THERAPEUTICS INC | 219,333 | $26.9m | 12.4% |
| SHATTUCK LABS INC | 3,727,348 | $25.9m | 11.9% |
| COMPASS PATHWAYS PLC | 1,775,759 | $25.1m | 11.6% |
| STRUCTURE THERAPEUTICS INC | 312,496 | $16.8m | 7.7% |
| VOR BIOPHARMA INC | 889,164 | $16.4m | 7.5% |
| RYTM RHYTHM PHARMACEUTICALS INC | 131,758 | $14.6m | 6.7% |
| PALVELLA THERAPEUTICS INC NE | 89,909 | $13.7m | 6.3% |
| XENE XENON PHARMACEUTICALS INC | 183,225 | $11.1m | 5.1% |
| ZENAS BIOPHARMA INC | 426,736 | $10.8m | 5.0% |
| ORIC PHARMACEUTICALS INC | 706,124 | $7.6m | 3.5% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2038158")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.